Common stock

10 Months Ended

Dec. 31, 2014

Equity [Abstract]

Common stock

Common stock

As of December 31, 2014, the Company had authorized 61,000,000 shares of common stock, $0.0001 par value per share. Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to the rights and privileges of the Series A and Series B Preferred Stock.

Restricted common stock

In March 2014, the Company sold 4,553,415 shares of restricted common stock to the founders of the Company ("recipients"), for $0.0004 per share, for total proceeds of $1,950. In April 2014, based upon anti-dilution provisions granted to the founders, an additional 867,314 shares of restricted common stock were sold to the same founders, after which the anti-dilution provisions were terminated. The restricted common stock vested 25% upon issuance, and the remaining 75% vests ratably over four years, during which time the Company has the right to repurchase the unvested shares held by a recipient if the relationship between such recipient and the Company ceases. If the relationship terminates, the Company has 90 days to repurchase unvested shares at $0.0004. Such shares are not accounted for as outstanding until they vest. There were 2,202,139 shares of restricted common stock outstanding as of December 31, 2014.

The following is a summary of restricted common stock activity:

	Number of Shares		Weighted-Average Grant Date Fair Value
Non-vested at February 26, 2014	—		$	—
Issued	5,420,729		0.10
Vested	(2,202,139	)	0.10
Forfeited	—		—
Non-vested at December 31, 2014	3,218,590		$	0.10

The total fair value of shares vested for the period from February 26, 2014 (inception) to December 31, 2014 was approximately $3,620,000.

Shares reserved for future issuance

The Company has reserved the following number of shares of common stock for future issuance:

	December 31, 2014
Vesting of restricted common stock	3,218,590
Conversion of Series A Preferred Stock	3,683,637
Conversion of Series B Preferred Stock	3,287,471
Stock-based compensation awards	1,189,314
Total	11,379,012